

NCT00397215 comparison:

Summary:
CHIA has 18 criteria while your personal folder has 18 criteria
Total found criteria: 18/18
Total not Found: 0/18
Total Extra: 1
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Subjects who the investigator believes that they   │ Subjects who the investigator believes that they   │
│ can and will comply with the requirements of the   │ can and will comply with the requirements of the   │
│ protocol should be enrolled in the study           │ protocol should be enrolled in the study           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ A male or female aged 61 years or above at the     │ A male or female aged 61 years or above at the     │
│ time of the first vaccination                      │ time of the first vaccination                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Written informed consent obtained from the subject │ Written informed consent obtained from the subject │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Healthy subjects or subjects with well controlled  │ Healthy subjects or subjects with well controlled  │
│ underlying disease                                 │ underlying disease                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Administration of the licensed MF59-containing     │ Administration of the licensed MF59-containing     │
│ vaccines, e.g. Fluad™ or Addigrip™ or virosome-    │ vaccines, e.g. Fluad™ or Addigrip™ or virosome-    │
│ based influenza vaccines such as Inflexal V™,      │ based influenza vaccines such as Inflexal V™,      │
│ InfectoVac Flu™ or Invivac™ during the 2006-2007   │ InfectoVac Flu™ or Invivac™ during the 2006-2007   │
│ influenza season                                   │ influenza season                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Administration of licensed vaccines within 2 weeks │ Administration of licensed vaccines within 2 weeks │
│ (for inactivated vaccines) or 4 weeks (for live    │ (for inactivated vaccines) or 4 weeks (for live    │
│ vaccines) prior to enrolment in this study         │ vaccines) prior to enrolment in this study         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Planned administration of a vaccine not foreseen   │ Planned administration of a vaccine not foreseen   │
│ by the study protocol up to 30 days after the      │ by the study protocol up to 30 days after the      │
│ second vaccination with H5N1 vaccine               │ second vaccination with H5N1 vaccine               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Chronic administration (defined as more than 14    │ Chronic administration (defined as more than 14    │
│ days) of immunosuppressants or other immune-       │ days) of immunosuppressants or other immune-       │
│ modifying drugs within six months prior to the     │ modifying drugs within six months prior to the     │
│ first administration of the study vaccine          │ first administration of the study vaccine          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Any confirmed or suspected immunosuppressive or    │ Any confirmed or suspected immunosuppressive or    │
│ immunodeficient condition, based on medical        │ immunodeficient condition, based on medical        │
│ history and physical examination (no laboratory    │ history and physical examination (no laboratory    │
│ testing required)                                  │ testing required)                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of chronic alcohol consumption and/or drug │ History of chronic alcohol consumption and/or drug │
│ abuse                                              │ abuse                                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of hypersensitivity to vaccines            │ History of hypersensitivity to vaccines            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of allergic disease or reactions likely to │ History of allergic disease or reactions likely to │
│ be exacerbated by any component of the vaccine     │ be exacerbated by any component of the vaccine     │
│ (including egg and thiomersal allergy)             │ (including egg and thiomersal allergy)             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Acute clinically significant pulmonary,            │ Acute clinically significant pulmonary,            │
│ cardiovascular, hepatic or renal functional        │ cardiovascular, hepatic or renal functional        │
│ abnormality, as determined by physical examination │ abnormality, as determined by physical examination │
│ or laboratory screening tests                      │ or laboratory screening tests                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Acute disease at the time of enrolment             │ Acute disease at the time of enrolment             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Serious chronic disease including any medically    │ Serious chronic disease including any medically    │
│ significant chronic pulmonary, cardiovascular,     │ significant chronic pulmonary, cardiovascular,     │
│ renal, neurological, psychiatric or metabolic      │ renal, neurological, psychiatric or metabolic      │
│ disorder, as determined by medical history and     │ disorder, as determined by medical history and     │
│ physical examination                               │ physical examination                               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Administration of immunoglobulins and/or any blood │ Administration of immunoglobulins and/or any blood │
│ products within the three months preceding the     │ products within the three months preceding the     │
│ first vaccination or during the study              │ first vaccination or during the study              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Use of any investigational or non-registered       │ Use of any investigational or non-registered       │
│ product (drug or vaccine) other than the study     │ product (drug or vaccine) other than the study     │
│ vaccine(s) within 30 days prior to the first       │ vaccine(s) within 30 days prior to the first       │
│ vaccination, or planned use during the study       │ vaccination, or planned use during the study       │
│ period                                             │ period                                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Any condition which, in the opinion of the         │ Any condition which, in the opinion of the         │
│ investigator, prevents the subject from            │ investigator, prevents the subject from            │
│ participation in the study                         │ participation in the study                         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 60 Years │
╘═══════════════════════════════════╛